Delivery Systems
Delivery Systems include various technologies to deliver Genome Editors into cells and tissues of cells and animals, and one day humans, to treat genetic or acquired diseases. This page contains information about in vitro and in vivo delivery systems used and developed by SCGE consortium projects.
146 results in Delivery Systems
113-O12BDelivery System - [In Vivo] [Delivery Systems Initiative] [Mouse] |
306-O12BDelivery System - [In Vivo, In Vitro] [Small Animal Testing Center (SATC), Delivery Systems Initiative] [Mouse]Show Experiments (5)
Testing new LNPs (lipid nanoparticles) for delivery of Cas9 mRNA/sgRNA in primary fibroblast cells from adult Ai14 mouse cochlea
|
306-O12B blankDelivery System - [In Vivo] [Small Animal Testing Center (SATC)] [Mouse] |
306-S10Delivery System - [In Vivo, In Vitro] [Small Animal Testing Center (SATC), Delivery Systems Initiative] [Mouse]Show Experiments (4)
Testing new LNPs (lipid nanoparticles) for delivery of Cas9 mRNA/sgRNA in primary fibroblast cells from adult Ai14 mouse cochlea
|
AAVDelivery System - [In Vivo, In Vitro] [Biological Effects Initiative, AAV tropism, Delivery Systems Initiative] [Human, Mouse]Show Experiments (9)
Cre Recombinase dose escalation study in Ai9 mice
|
AAV+Focused UltrasoundDelivery System - [In Vivo] [Delivery Systems Initiative] [Mouse]Show Experiments (1) |
D10Delivery System - [In Vivo] [Small Animal Testing Center (SATC)] [Mouse] |
D237Delivery System - [In Vivo] [Small Animal Testing Center (SATC)] [Mouse] |
FS48Delivery System - [In Vitro] [Delivery Systems Initiative] [Human]Show Experiments (1)
Peptide Shuttle optimization to deliver Cas9 RNP to human airway epithelia cells
|
FS66d6Delivery System - [In Vitro] [Delivery Systems Initiative] [Human] |
FSD112Delivery System - [In Vitro] [Delivery Systems Initiative] [Human] |
FSD114Delivery System - [In Vitro] [Delivery Systems Initiative] [Human] |
FSD114d1Delivery System - [In Vitro] [Collaborative Opportunity Fund, Delivery Systems Initiative] [Human]Show Experiments (3)
Peptide Shuttle optimization to deliver Cas9 RNP to human airway epithelia cells
|
FSD115Delivery System - [In Vitro] [Delivery Systems Initiative] [Human] |
FSD115d1Delivery System - [In Vitro] [Collaborative Opportunity Fund, Delivery Systems Initiative] [Human]Show Experiments (3)
Peptide Shuttle optimization to deliver Cas9 RNP to human airway epithelia cells
|
FSD116d1Delivery System - [In Vitro] [Delivery Systems Initiative] [Human] |
FSD117D1Delivery System - [In Vitro] [Delivery Systems Initiative] [Human] |
FSD118Delivery System - [In Vitro] [Delivery Systems Initiative] [Human] |
FSD121Delivery System - [In Vitro] [Delivery Systems Initiative] [Human] |
FSD122Delivery System - [In Vitro] [Delivery Systems Initiative] [Human] |
FSD132Delivery System - [In Vitro] [Delivery Systems Initiative] [Human] |
FSD147Delivery System - [In Vitro] [Delivery Systems Initiative] [Human] |
FSD159Delivery System - [In Vitro] [Delivery Systems Initiative] [Human] |
FSD160Delivery System - [In Vitro] [Delivery Systems Initiative] [Human] |
FSD168Delivery System - [In Vitro] [Delivery Systems Initiative] [Human] |
FSD168 Disul.Delivery System - [In Vitro] [Delivery Systems Initiative] [Human] |
FSD168 Scr.Delivery System - [In Vitro] [Delivery Systems Initiative] [Human] |
FSD168 cyclicDelivery System - [In Vitro] [Delivery Systems Initiative] [Human] |
FSD168D20Delivery System - [In Vitro] [Delivery Systems Initiative] [Human]Show Experiments (1)
Peptide Shuttle optimization to deliver Cas9 RNP to human airway epithelia cells
|
FSD168d10Delivery System - [In Vitro] [Delivery Systems Initiative] [Human] |
FSD168d11Delivery System - [In Vitro] [Delivery Systems Initiative] [Human] |
FSD168d12Delivery System - [In Vitro] [Delivery Systems Initiative] [Human] |
FSD168d17Delivery System - [In Vitro] [Delivery Systems Initiative] [Human] |
FSD168d20Delivery System - [In Vitro] [Delivery Systems Initiative] [Human]Show Experiments (1)
Peptide Shuttle optimization to deliver Cas12a RNP to human airway epithelia cells
|
FSD186Delivery System - [In Vitro] [Delivery Systems Initiative] [Human] |
FSD188Delivery System - [In Vitro] [Delivery Systems Initiative] [Human] |
FSD189Delivery System - [In Vitro] [Delivery Systems Initiative] [Human] |
FSD190Delivery System - [In Vitro] [Delivery Systems Initiative] [Human] |
FSD191Delivery System - [In Vitro] [Delivery Systems Initiative] [Human] |
FSD193Delivery System - [In Vitro] [Delivery Systems Initiative] [Human] |
FSD195Delivery System - [In Vitro] [Collaborative Opportunity Fund, Delivery Systems Initiative] [Human]Show Experiments (3)
Peptide Shuttle optimization to deliver Cas9 RNP to human airway epithelia cells
|
FSD196Delivery System - [In Vitro] [Delivery Systems Initiative] [Human] |
FSD197Delivery System - [In Vitro] [Collaborative Opportunity Fund, Delivery Systems Initiative] [Human]Show Experiments (3)
Peptide Shuttle optimization to deliver Cas9 RNP to human airway epithelia cells
|
FSD199Delivery System - [In Vitro] [Delivery Systems Initiative] [Human] |
FSD215Delivery System - [In Vitro] [Delivery Systems Initiative] [Human] |
FSD216Delivery System - [In Vitro] [Delivery Systems Initiative] [Human] |
FSD222Delivery System - [In Vitro] [Delivery Systems Initiative] [Human] |
FSD227Delivery System - [In Vitro] [Delivery Systems Initiative] [Human] |
FSD228Delivery System - [In Vitro] [Delivery Systems Initiative] [Human] |
FSD234Delivery System - [In Vitro] [Delivery Systems Initiative] [Human] |
FSD235Delivery System - [In Vitro] [Delivery Systems Initiative] [Human] |
FSD236Delivery System - [In Vitro] [Delivery Systems Initiative] [Human] |
FSD237Delivery System - [In Vitro] [Collaborative Opportunity Fund, Delivery Systems Initiative] [Human, Rhesus macaque]Show Experiments (5)
Peptide Shuttle optimization to deliver Cas9 RNP to human airway epithelia cells
|
FSD238Delivery System - [In Vitro] [Collaborative Opportunity Fund, Delivery Systems Initiative] [Human]Show Experiments (3)
Peptide Shuttle optimization to deliver Cas9 RNP to human airway epithelia cells
|
FSD239Delivery System - [In Vitro] [Delivery Systems Initiative] [Human] |
FSD240Delivery System - [In Vitro] [Delivery Systems Initiative] [Human] |
FSD259Delivery System - [In Vitro] [Delivery Systems Initiative] [Human] |
FSD260Delivery System - [In Vitro] [Delivery Systems Initiative] [Human] |
FSD262Delivery System - [In Vitro] [Collaborative Opportunity Fund, Delivery Systems Initiative] [Human, Rhesus macaque]Show Experiments (4)
Peptide Shuttle optimization to deliver Cas9 RNP to human airway epithelia cells
|
FSD283Delivery System - [In Vitro] [Delivery Systems Initiative] [Human] |
FSD284Delivery System - [In Vitro] [Delivery Systems Initiative] [Human] |
FSD285Delivery System - [In Vitro] [Collaborative Opportunity Fund, Delivery Systems Initiative] [Human]Show Experiments (3)
Peptide Shuttle optimization to deliver Cas9 RNP to human airway epithelia cells
|
FSD286Delivery System - [In Vitro] [Delivery Systems Initiative] [Human] |
FSD287Delivery System - [In Vitro] [Delivery Systems Initiative] [Human] |
FSD288Delivery System - [In Vitro] [Delivery Systems Initiative] [Human] |
FSD289Delivery System - [In Vitro] [Delivery Systems Initiative] [Human] |
FSD291Delivery System - [In Vitro] [Delivery Systems Initiative] [Human] |
FSD293Delivery System - [In Vitro] [Delivery Systems Initiative] [Human] |
FSD297Delivery System - [In Vitro] [Delivery Systems Initiative] [Human] |
FSD301Delivery System - [In Vitro] [Collaborative Opportunity Fund, Delivery Systems Initiative] [Human]Show Experiments (3)
Peptide Shuttle optimization to deliver Cas9 RNP to human airway epithelia cells
|
FSD303Delivery System - [In Vitro] [Delivery Systems Initiative] [Human] |
FSD304Delivery System - [In Vitro] [Delivery Systems Initiative] [Human] |
FSD305Delivery System - [In Vitro] [Delivery Systems Initiative] [Human] |
FSD306Delivery System - [In Vitro] [Delivery Systems Initiative] [Human] |
FSD307Delivery System - [In Vitro] [Delivery Systems Initiative] [Human] |
FSD308Delivery System - [In Vitro] [Delivery Systems Initiative] [Human] |
FSD310Delivery System - [In Vitro] [Delivery Systems Initiative] [Human] |
FSD315Delivery System - [In Vivo, In Vitro] [Collaborative Opportunity Fund, Delivery Systems Initiative] [Human, Rhesus macaque]Show Experiments (7)
Peptide Shuttle optimization to deliver Cas9 RNP to human airway epithelia cells
|
FSD316Delivery System - [In Vitro] [Delivery Systems Initiative] [Human] |
FSD317Delivery System - [In Vitro] [Delivery Systems Initiative] [Human] |
FSD318Delivery System - [In Vitro] [Delivery Systems Initiative] [Human] |
FSD319Delivery System - [In Vitro] [Delivery Systems Initiative] [Human] |
FSD321Delivery System - [In Vitro] [Collaborative Opportunity Fund, Delivery Systems Initiative] [Human, Rhesus macaque]Show Experiments (4)
Peptide Shuttle optimization to deliver Cas9 RNP to human airway epithelia cells
|
FSD322Delivery System - [In Vitro] [Delivery Systems Initiative] [Human] |
FSD323Delivery System - [In Vitro] [Delivery Systems Initiative] [Human] |
FSD329Delivery System - [In Vitro] [Delivery Systems Initiative] [Human] |
FSD330Delivery System - [In Vitro] [Delivery Systems Initiative] [Human] |
FSD331Delivery System - [In Vitro] [Delivery Systems Initiative] [Human] |
FSD332Delivery System - [In Vitro] [Delivery Systems Initiative] [Human] |
FSD333Delivery System - [In Vitro] [Delivery Systems Initiative] [Human] |
FSD334Delivery System - [In Vitro] [Delivery Systems Initiative] [Human] |
FSD335Delivery System - [In Vitro] [Delivery Systems Initiative] [Human] |
FSD339Delivery System - [In Vitro] [Delivery Systems Initiative] [Human] |
FSD341Delivery System - [In Vitro] [Delivery Systems Initiative] [Human] |
FSD347Delivery System - [In Vitro] [Delivery Systems Initiative] [Human] |
FSD359Delivery System - [In Vitro] [Delivery Systems Initiative] [Human] |
FSD360Delivery System - [In Vitro] [Delivery Systems Initiative] [Human] |
FSD361Delivery System - [In Vitro] [Delivery Systems Initiative] [Human] |
FSD362Delivery System - [In Vitro] [Delivery Systems Initiative] [Human] |
FSD363Delivery System - [In Vitro] [Delivery Systems Initiative] [Human] |
FSD364Delivery System - [In Vitro] [Delivery Systems Initiative] [Human] |
FSD365Delivery System - [In Vitro] [Delivery Systems Initiative] [Human] |
FSD366Delivery System - [In Vitro] [Delivery Systems Initiative] [Human] |
FSD367Delivery System - [In Vitro] [Delivery Systems Initiative] [Human] |
FSD368Delivery System - [In Vitro] [Delivery Systems Initiative] [Human] |
FSD57Delivery System - [In Vitro] [Delivery Systems Initiative] [Human] |
FSD57d1Delivery System - [In Vitro] [Delivery Systems Initiative] [Human] |
FSD57d3Delivery System - [In Vitro] [Delivery Systems Initiative] [Human] |
FSD57d4Delivery System - [In Vitro] [Delivery Systems Initiative] [Human] |
FSD57d5Delivery System - [In Vitro] [Delivery Systems Initiative] [Human] |
FSD57d6Delivery System - [In Vitro] [Delivery Systems Initiative] [Human] |
FSD63Delivery System - [In Vitro] [Delivery Systems Initiative] [Human] |
FSD63D1Delivery System - [In Vitro] [Collaborative Opportunity Fund, Delivery Systems Initiative] [Human, Rhesus macaque]Show Experiments (3)
Peptide Shuttle optimization to deliver Cas9 RNP to human airway epithelia cells
|
FSD67Delivery System - [In Vitro] [Delivery Systems Initiative] [Human] |
FSD94Delivery System - [In Vitro] [Delivery Systems Initiative] [Human] |
FSD95Delivery System - [In Vitro] [Collaborative Opportunity Fund, Delivery Systems Initiative] [Human, Rhesus macaque]Show Experiments (3)
Peptide Shuttle optimization to deliver Cas9 RNP to human airway epithelia cells
|
FSD96Delivery System - [In Vitro] [Delivery Systems Initiative] [Human] |
FSD97Delivery System - [In Vitro] [Delivery Systems Initiative] [Human] |
FSX1Delivery System - [In Vitro] [Delivery Systems Initiative] [Human] |
FSX2Delivery System - [In Vitro] [Delivery Systems Initiative] [Human] |
FSX3Delivery System - [In Vitro] [Delivery Systems Initiative] [Human] |
FSX4Delivery System - [In Vitro] [Delivery Systems Initiative] [Human] |
FSX5Delivery System - [In Vitro] [Delivery Systems Initiative] [Human] |
FSX6Delivery System - [In Vitro] [Delivery Systems Initiative] [Human] |
FSX7Delivery System - [In Vitro] [Delivery Systems Initiative] [Human] |
FSX8Delivery System - [In Vitro] [Delivery Systems Initiative] [Human] |
Lipofectamine 3000Delivery System - [In Vitro] [Genome Editors, Delivery Systems Initiative] [Human] |
P3 Nucleofection KitDelivery System - [In Vitro] [Biological Systems] [Human]Show Experiments (1)
A novel human T cell platform to define biological adverse effects of genome editing
|
RNP-NC-CPPDelivery System - [In Vivo, In Vitro] [Small Animal Testing Center (SATC), Collaborative Opportunity Fund, Delivery Systems Initiative] [Human, Mouse]Show Experiments (5)
Enabling Nanoplatforms for Targeted in vivo Delivery of CRISPR/Cas9 Ribonucleoproteins in the Brain.
|
RNP-NC-RVGDelivery System - [In Vivo] [Small Animal Testing Center (SATC)] [Mouse] |
RNP-NC-no ligandDelivery System - [In Vivo, In Vitro] [Small Animal Testing Center (SATC), Collaborative Opportunity Fund, Delivery Systems Initiative] [Human, Mouse]Show Experiments (3)
Enabling Nanoplatforms for Targeted in vivo Delivery of CRISPR/Cas9 Ribonucleoproteins in the Brain.
|
RNP-NC-no ligand with Lipofectamine 2000Delivery System - [In Vitro] [Collaborative Opportunity Fund] [Human]Show Experiments (3)
Testing different ratios of Lipofectamine-RNPs after 24 hours for determination of positive control
|
RNP-NC-no ligand with Lipofectamine 2001Delivery System - [In Vitro] [Collaborative Opportunity Fund] [Human] |
RNP-NC-no ligand with Lipofectamine 2002Delivery System - [In Vitro] [Collaborative Opportunity Fund] [Human] |
RNP-NC-tri(GalNAc)Delivery System - [In Vitro] [Collaborative Opportunity Fund] [Human]Show Experiments (3)
Testing different ratios of Lipofectamine-RNPs after 24 hours for determination of positive control
|
S10Delivery System - [In Vivo, In Vitro] [Collaborative Opportunity Fund, Delivery Systems Initiative] [Human, Mouse, Rhesus macaque]Show Experiments (12)
Testing Shuttle Peptides ability to deliver GFP-NLS to airway epithelia.
|
S10 Scr.Delivery System - [In Vitro] [Delivery Systems Initiative] [Human] |
S10-MODDelivery System - [In Vitro] [Delivery Systems Initiative] [Human] |
S10DDelivery System - [In Vitro] [Delivery Systems Initiative] [Human] |
SE Cell Line 4D-Nucleofectorâ„¢ X Kit SDelivery System - [In Vitro] [Collaborative Opportunity Fund] [Rhesus macaque] |
eVLPDelivery System - [In Vivo] [Small Animal Testing Center (SATC), Delivery Systems Initiative] [Mouse]Show Experiments (3)
Pcsk9 adenine base editor efficiency in liver and nonliver tissue
|
endosomolytic peptideDelivery System - [In Vitro] [Collaborative Opportunity Fund] [Human]Show Experiments (1) |
endosomolytic peptide and anti-podocyte targeting antibodyDelivery System - [In Vitro] [Collaborative Opportunity Fund] [Human]Show Experiments (1) |
146 results in Delivery Systems
Type | Subtype | Name | Description | Source | View Associated.. |
---|---|---|---|---|---|
Nanoparticle | Cationic lipid | 113-O12B | combinatorial library cationic lipid nanoparticles | Xu lab | |
Nanoparticle | Cationic lipid | 306-O12B | Combinatorial library cationic lipid nanoparticles | Xu lab |
Show Experiments (5)
Testing new LNPs (lipid nanoparticles) for delivery of Cas9 mRNA/sgRNA in primary fibroblast cells from adult Ai14 mouse cochlea
|
Nanoparticle | Cationic lipid | 306-O12B blank | Combinatorial library cationic lipid nanoparticles | Xu lab | |
Nanoparticle | Cationic lipid | 306-S10 | combinatorial library cationic lipid nanoparticles | Xu lab |
Show Experiments (4)
Testing new LNPs (lipid nanoparticles) for delivery of Cas9 mRNA/sgRNA in primary fibroblast cells from adult Ai14 mouse cochlea
|
Viral vector | Adeno Associated Virus (AAV) | AAV | See vector details |
Show Experiments (9)
Cre Recombinase dose escalation study in Ai9 mice
|
|
Viral vector | Adeno Associated Virus | AAV+Focused Ultrasound | See vector details | Leong Lab |
Show Experiments (1) |
Amphiphilic peptide | CM18-PTD4 | Shuttle peptide | Feldan Therapeutics (synthetic peptide from GL Biochem, 95% purity) | ||
Amphiphilic peptide | D10 | McCray Lab | |||
Amphiphilic peptide | D237 | McCray Lab | |||
Amphiphilic peptide | FS48 | Shuttle peptide used to deliver reagents to airway epithelia | McCray Lab |
Show Experiments (1)
Peptide Shuttle optimization to deliver Cas9 RNP to human airway epithelia cells
|
|
Amphiphilic peptide | FS66d6 | Shuttle peptide used to deliver reagents to airway epithelia | McCray Lab | ||
Amphiphilic peptide | FSD112 | Shuttle peptide used to deliver reagents to airway epithelia | McCray Lab | ||
Amphiphilic peptide | FSD114 | Shuttle peptide used to deliver reagents to airway epithelia | McCray Lab | ||
Amphiphilic peptide | FSD114d1 | Shuttle peptide used to deliver reagents to airway epithelia | McCray Lab |
Show Experiments (3)
Peptide Shuttle optimization to deliver Cas9 RNP to human airway epithelia cells
|
|
Amphiphilic peptide | FSD115 | Shuttle peptide used to deliver reagents to airway epithelia | McCray Lab | ||
Amphiphilic peptide | FSD115d1 | Shuttle peptide used to deliver reagents to airway epithelia | McCray Lab |
Show Experiments (3)
Peptide Shuttle optimization to deliver Cas9 RNP to human airway epithelia cells
|
|
Amphiphilic peptide | FSD116d1 | Shuttle peptide used to deliver reagents to airway epithelia | McCray Lab | ||
Amphiphilic peptide | FSD117D1 | Shuttle peptide used to deliver reagents to airway epithelia | McCray Lab | ||
Amphiphilic peptide | FSD118 | Shuttle peptide used to deliver reagents to airway epithelia | McCray Lab | ||
Amphiphilic peptide | FSD121 | Shuttle peptide used to deliver reagents to airway epithelia | McCray Lab | ||
Amphiphilic peptide | FSD122 | Shuttle peptide used to deliver reagents to airway epithelia | McCray Lab | ||
Amphiphilic peptide | FSD132 | Shuttle peptide used to deliver reagents to airway epithelia | McCray Lab | ||
Amphiphilic peptide | FSD147 | Shuttle peptide used to deliver reagents to airway epithelia | McCray Lab | ||
Amphiphilic peptide | FSD159 | Shuttle peptide used to deliver reagents to airway epithelia | McCray Lab | ||
Amphiphilic peptide | FSD160 | Shuttle peptide used to deliver reagents to airway epithelia | McCray Lab | ||
Amphiphilic peptide | FSD168 | Shuttle peptide used to deliver reagents to airway epithelia | McCray Lab | ||
Amphiphilic peptide | FSD168 Disul. | Shuttle peptide used to deliver reagents to airway epithelia | McCray Lab | ||
Amphiphilic peptide | FSD168 Scr. | Shuttle peptide used to deliver reagents to airway epithelia | McCray Lab | ||
Amphiphilic peptide | FSD168 cyclic | Shuttle peptide used to deliver reagents to airway epithelia | McCray Lab | ||
Amphiphilic peptide | FSD168D20 | Shuttle peptide used to deliver reagents to airway epithelia | McCray Lab |
Show Experiments (1)
Peptide Shuttle optimization to deliver Cas9 RNP to human airway epithelia cells
|
|
Amphiphilic peptide | FSD168d10 | Shuttle peptide used to deliver reagents to airway epithelia | McCray Lab | ||
Amphiphilic peptide | FSD168d11 | Shuttle peptide used to deliver reagents to airway epithelia | McCray Lab | ||
Amphiphilic peptide | FSD168d12 | Shuttle peptide used to deliver reagents to airway epithelia | McCray Lab | ||
Amphiphilic peptide | FSD168d17 | Shuttle peptide used to deliver reagents to airway epithelia | McCray Lab | ||
Amphiphilic peptide | FSD168d20 | Shuttle peptide | Feldan Therapeutics (synthetic peptide from GL Biochem, 95% purity) |
Show Experiments (1)
Peptide Shuttle optimization to deliver Cas12a RNP to human airway epithelia cells
|
|
Amphiphilic peptide | FSD186 | Shuttle peptide used to deliver reagents to airway epithelia | McCray Lab | ||
Amphiphilic peptide | FSD188 | Shuttle peptide used to deliver reagents to airway epithelia | McCray Lab | ||
Amphiphilic peptide | FSD189 | Shuttle peptide used to deliver reagents to airway epithelia | McCray Lab | ||
Amphiphilic peptide | FSD190 | Shuttle peptide used to deliver reagents to airway epithelia | McCray Lab | ||
Amphiphilic peptide | FSD191 | Shuttle peptide used to deliver reagents to airway epithelia | McCray Lab | ||
Amphiphilic peptide | FSD193 | Shuttle peptide used to deliver reagents to airway epithelia | McCray Lab | ||
Amphiphilic peptide | FSD195 | Shuttle peptide used to deliver reagents to airway epithelia | McCray Lab |
Show Experiments (3)
Peptide Shuttle optimization to deliver Cas9 RNP to human airway epithelia cells
|
|
Amphiphilic peptide | FSD196 | Shuttle peptide used to deliver reagents to airway epithelia | McCray Lab | ||
Amphiphilic peptide | FSD197 | Shuttle peptide used to deliver reagents to airway epithelia | McCray Lab |
Show Experiments (3)
Peptide Shuttle optimization to deliver Cas9 RNP to human airway epithelia cells
|
|
Amphiphilic peptide | FSD199 | Shuttle peptide used to deliver reagents to airway epithelia | McCray Lab | ||
Amphiphilic peptide | FSD215 | Shuttle peptide used to deliver reagents to airway epithelia | McCray Lab | ||
Amphiphilic peptide | FSD216 | Shuttle peptide used to deliver reagents to airway epithelia | McCray Lab | ||
Amphiphilic peptide | FSD222 | Shuttle peptide used to deliver reagents to airway epithelia | McCray Lab | ||
Amphiphilic peptide | FSD227 | Shuttle peptide used to deliver reagents to airway epithelia | McCray Lab | ||
Amphiphilic peptide | FSD228 | Shuttle peptide used to deliver reagents to airway epithelia | McCray Lab | ||
Amphiphilic peptide | FSD234 | Shuttle peptide used to deliver reagents to airway epithelia | McCray Lab | ||
Amphiphilic peptide | FSD235 | Shuttle peptide used to deliver reagents to airway epithelia | McCray Lab | ||
Amphiphilic peptide | FSD236 | Shuttle peptide used to deliver reagents to airway epithelia | McCray Lab | ||
Amphiphilic peptide | FSD237 | Shuttle peptide used to deliver reagents to airway epithelia | McCray Lab |
Show Experiments (5)
Peptide Shuttle optimization to deliver Cas9 RNP to human airway epithelia cells
|
|
Amphiphilic peptide | FSD238 | Shuttle peptide used to deliver reagents to airway epithelia | McCray Lab |
Show Experiments (3)
Peptide Shuttle optimization to deliver Cas9 RNP to human airway epithelia cells
|
|
Amphiphilic peptide | FSD239 | Shuttle peptide used to deliver reagents to airway epithelia | McCray Lab | ||
Amphiphilic peptide | FSD240 | Shuttle peptide used to deliver reagents to airway epithelia | McCray Lab | ||
Amphiphilic peptide | FSD259 | Shuttle peptide used to deliver reagents to airway epithelia | McCray Lab | ||
Amphiphilic peptide | FSD260 | Shuttle peptide used to deliver reagents to airway epithelia | McCray Lab | ||
Amphiphilic peptide | FSD262 | Shuttle peptide used to deliver reagents to airway epithelia | McCray Lab |
Show Experiments (4)
Peptide Shuttle optimization to deliver Cas9 RNP to human airway epithelia cells
|
|
Amphiphilic peptide | FSD283 | Shuttle peptide used to deliver reagents to airway epithelia | McCray Lab | ||
Amphiphilic peptide | FSD284 | Shuttle peptide used to deliver reagents to airway epithelia | McCray Lab | ||
Amphiphilic peptide | FSD285 | Shuttle peptide used to deliver reagents to airway epithelia | McCray Lab |
Show Experiments (3)
Peptide Shuttle optimization to deliver Cas9 RNP to human airway epithelia cells
|
|
Amphiphilic peptide | FSD286 | Shuttle peptide used to deliver reagents to airway epithelia | McCray Lab | ||
Amphiphilic peptide | FSD287 | Shuttle peptide used to deliver reagents to airway epithelia | McCray Lab | ||
Amphiphilic peptide | FSD288 | Shuttle peptide used to deliver reagents to airway epithelia | McCray Lab | ||
Amphiphilic peptide | FSD289 | Shuttle peptide used to deliver reagents to airway epithelia | McCray Lab | ||
Amphiphilic peptide | FSD291 | Shuttle peptide used to deliver reagents to airway epithelia | McCray Lab | ||
Amphiphilic peptide | FSD293 | Shuttle peptide used to deliver reagents to airway epithelia | McCray Lab | ||
Amphiphilic peptide | FSD297 | Shuttle peptide used to deliver reagents to airway epithelia | McCray Lab | ||
Amphiphilic peptide | FSD301 | Shuttle peptide used to deliver reagents to airway epithelia | McCray Lab |
Show Experiments (3)
Peptide Shuttle optimization to deliver Cas9 RNP to human airway epithelia cells
|
|
Amphiphilic peptide | FSD303 | Shuttle peptide used to deliver reagents to airway epithelia | McCray Lab | ||
Amphiphilic peptide | FSD304 | Shuttle peptide used to deliver reagents to airway epithelia | McCray Lab | ||
Amphiphilic peptide | FSD305 | Shuttle peptide used to deliver reagents to airway epithelia | McCray Lab | ||
Amphiphilic peptide | FSD306 | Shuttle peptide used to deliver reagents to airway epithelia | McCray Lab | ||
Amphiphilic peptide | FSD307 | Shuttle peptide used to deliver reagents to airway epithelia | McCray Lab | ||
Amphiphilic peptide | FSD308 | Shuttle peptide used to deliver reagents to airway epithelia | McCray Lab | ||
Amphiphilic peptide | FSD310 | Shuttle peptide used to deliver reagents to airway epithelia | McCray Lab | ||
Amphiphilic peptide | FSD315 | Shuttle peptide used to deliver reagents to airway epithelia | McCray Lab |
Show Experiments (7)
Peptide Shuttle optimization to deliver Cas9 RNP to human airway epithelia cells
|
|
Amphiphilic peptide | FSD316 | Shuttle peptide used to deliver reagents to airway epithelia | McCray Lab | ||
Amphiphilic peptide | FSD317 | Shuttle peptide used to deliver reagents to airway epithelia | McCray Lab | ||
Amphiphilic peptide | FSD318 | Shuttle peptide used to deliver reagents to airway epithelia | McCray Lab | ||
Amphiphilic peptide | FSD319 | Shuttle peptide used to deliver reagents to airway epithelia | McCray Lab | ||
Amphiphilic peptide | FSD321 | Shuttle peptide used to deliver reagents to airway epithelia | McCray Lab |
Show Experiments (4)
Peptide Shuttle optimization to deliver Cas9 RNP to human airway epithelia cells
|
|
Amphiphilic peptide | FSD322 | Shuttle peptide used to deliver reagents to airway epithelia | McCray Lab | ||
Amphiphilic peptide | FSD323 | Shuttle peptide used to deliver reagents to airway epithelia | McCray Lab | ||
Amphiphilic peptide | FSD329 | Shuttle peptide used to deliver reagents to airway epithelia | McCray Lab | ||
Amphiphilic peptide | FSD330 | Shuttle peptide used to deliver reagents to airway epithelia | McCray Lab | ||
Amphiphilic peptide | FSD331 | Shuttle peptide used to deliver reagents to airway epithelia | McCray Lab | ||
Amphiphilic peptide | FSD332 | Shuttle peptide used to deliver reagents to airway epithelia | McCray Lab | ||
Amphiphilic peptide | FSD333 | Shuttle peptide used to deliver reagents to airway epithelia | McCray Lab | ||
Amphiphilic peptide | FSD334 | Shuttle peptide used to deliver reagents to airway epithelia | McCray Lab | ||
Amphiphilic peptide | FSD335 | Shuttle peptide used to deliver reagents to airway epithelia | McCray Lab | ||
Amphiphilic peptide | FSD339 | Shuttle peptide used to deliver reagents to airway epithelia | McCray Lab | ||
Amphiphilic peptide | FSD341 | Shuttle peptide used to deliver reagents to airway epithelia | McCray Lab | ||
Amphiphilic peptide | FSD347 | Shuttle peptide used to deliver reagents to airway epithelia | McCray Lab | ||
Amphiphilic peptide | FSD359 | Shuttle peptide used to deliver reagents to airway epithelia | McCray Lab | ||
Amphiphilic peptide | FSD360 | Shuttle peptide used to deliver reagents to airway epithelia | McCray Lab | ||
Amphiphilic peptide | FSD361 | Shuttle peptide used to deliver reagents to airway epithelia | McCray Lab | ||
Amphiphilic peptide | FSD362 | Shuttle peptide used to deliver reagents to airway epithelia | McCray Lab | ||
Amphiphilic peptide | FSD363 | Shuttle peptide used to deliver reagents to airway epithelia | McCray Lab | ||
Amphiphilic peptide | FSD364 | Shuttle peptide used to deliver reagents to airway epithelia | McCray Lab | ||
Amphiphilic peptide | FSD365 | Shuttle peptide used to deliver reagents to airway epithelia | McCray Lab | ||
Amphiphilic peptide | FSD366 | Shuttle peptide used to deliver reagents to airway epithelia | McCray Lab | ||
Amphiphilic peptide | FSD367 | Shuttle peptide used to deliver reagents to airway epithelia | McCray Lab | ||
Amphiphilic peptide | FSD368 | Shuttle peptide used to deliver reagents to airway epithelia | McCray Lab | ||
Amphiphilic peptide | FSD57 | Shuttle peptide used to deliver reagents to airway epithelia | McCray Lab | ||
Amphiphilic peptide | FSD57d1 | Shuttle peptide used to deliver reagents to airway epithelia | McCray Lab | ||
Amphiphilic peptide | FSD57d3 | Shuttle peptide used to deliver reagents to airway epithelia | McCray Lab | ||
Amphiphilic peptide | FSD57d4 | Shuttle peptide used to deliver reagents to airway epithelia | McCray Lab | ||
Amphiphilic peptide | FSD57d5 | Shuttle peptide used to deliver reagents to airway epithelia | McCray Lab | ||
Amphiphilic peptide | FSD57d6 | Shuttle peptide used to deliver reagents to airway epithelia | McCray Lab | ||
Amphiphilic peptide | FSD63 | Shuttle peptide used to deliver reagents to airway epithelia | McCray Lab | ||
Amphiphilic peptide | FSD63D1 | Shuttle peptide used to deliver reagents to airway epithelia | McCray Lab |
Show Experiments (3)
Peptide Shuttle optimization to deliver Cas9 RNP to human airway epithelia cells
|
|
Amphiphilic peptide | FSD67 | Shuttle peptide used to deliver reagents to airway epithelia | McCray Lab | ||
Amphiphilic peptide | FSD94 | Shuttle peptide used to deliver reagents to airway epithelia | McCray Lab | ||
Amphiphilic peptide | FSD95 | Shuttle peptide used to deliver reagents to airway epithelia | McCray Lab |
Show Experiments (3)
Peptide Shuttle optimization to deliver Cas9 RNP to human airway epithelia cells
|
|
Amphiphilic peptide | FSD96 | Shuttle peptide used to deliver reagents to airway epithelia | McCray Lab | ||
Amphiphilic peptide | FSD97 | Shuttle peptide used to deliver reagents to airway epithelia | McCray Lab | ||
Amphiphilic peptide | FSX1 | Shuttle peptide used to deliver reagents to airway epithelia | McCray Lab | ||
Amphiphilic peptide | FSX2 | Shuttle peptide used to deliver reagents to airway epithelia | McCray Lab | ||
Amphiphilic peptide | FSX3 | Shuttle peptide used to deliver reagents to airway epithelia | McCray Lab | ||
Amphiphilic peptide | FSX4 | Shuttle peptide used to deliver reagents to airway epithelia | McCray Lab | ||
Amphiphilic peptide | FSX5 | Shuttle peptide used to deliver reagents to airway epithelia | McCray Lab | ||
Amphiphilic peptide | FSX6 | Shuttle peptide used to deliver reagents to airway epithelia | McCray Lab | ||
Amphiphilic peptide | FSX7 | Shuttle peptide used to deliver reagents to airway epithelia | McCray Lab | ||
Amphiphilic peptide | FSX8 | Shuttle peptide used to deliver reagents to airway epithelia | McCray Lab | ||
Commercial Reagent | Lipofectamine 3000 | Lipid nanoparticle | Thermo Fisher Scientific | ||
Commercial Reagent | P3 Nucleofection Kit | Nuceleofection kit to be used with Lonza's nucleofection system. | Lonza #V4SP-3096 |
Show Experiments (1)
A novel human T cell platform to define biological adverse effects of genome editing
|
|
Nanoparticle | Polymer-RNP nanocapsule | RNP-NC-CPP | The nanocapsule is a thin glutathione (GSH)-cleavable covalently crosslinked polymer coating around a preassembled ribonucleoprotein (RNP) complex between a Cas9 nuclease and an sgRNA. This nanoparticle has an addition of a cell penetrating peptide (CPP) from the TAT peptide (GRKKRRQRRRPQ) which lacks cell-type specficity | Gong Lab |
Show Experiments (5)
Enabling Nanoplatforms for Targeted in vivo Delivery of CRISPR/Cas9 Ribonucleoproteins in the Brain.
|
Nanoparticle | Polymer-RNP nanocapsule | RNP-NC-RVG | The nanocapsule is a thin glutathione (GSH)-cleavable covalently crosslinked polymer coating around a preassembled ribonucleoprotein (RNP) complex between a Cas9 nuclease and an sgRNA. This nanoparticle has an addition of a RVG peptide YTIWMPENPRPGTPCDIFTNSRGKRASNG which specifically interacts withthe N-acetylecholine receptor (AchR) on neuronal cells, which mediates NP entry | Gong Lab | |
Nanoparticle | Polymer-RNP nanocapsule | RNP-NC-no ligand | The nanocapsule is a thin glutathione (GSH)-cleavable covalently crosslinked polymer coating around a preassembled ribonucleoprotein (RNP) complex between a Cas9 nuclease and an sgRNA. | Gong Lab |
Show Experiments (3)
Enabling Nanoplatforms for Targeted in vivo Delivery of CRISPR/Cas9 Ribonucleoproteins in the Brain.
|
Nanoparticle | Polymer-RNP nanocapsule | RNP-NC-no ligand with Lipofectamine 2000 | The nanocapsule is a thin glutathione (GSH)-cleavable covalently crosslinked polymer coating around a preassembled ribonucleoprotein (RNP) complex between a Cas9 nuclease and an sgRNA. RNP was combined in various ratios with Lipofectamine 2000 (Thermo, cat# 11668030) to determine a positive control. | Gong Lab |
Show Experiments (3)
Testing different ratios of Lipofectamine-RNPs after 24 hours for determination of positive control
|
Nanoparticle | Polymer-RNP nanocapsule | RNP-NC-no ligand with Lipofectamine 2001 | The nanocapsule is a thin glutathione (GSH)-cleavable covalently crosslinked polymer coating around a preassembled ribonucleoprotein (RNP) complex between a Cas9 nuclease and an sgRNA. RNP was combined in various ratios with Lipofectamine 2000 (Thermo, cat# 11668030) to determine a positive control. | Gong Lab | |
Nanoparticle | Polymer-RNP nanocapsule | RNP-NC-no ligand with Lipofectamine 2002 | The nanocapsule is a thin glutathione (GSH)-cleavable covalently crosslinked polymer coating around a preassembled ribonucleoprotein (RNP) complex between a Cas9 nuclease and an sgRNA. RNP was combined in various ratios with Lipofectamine 2000 (Thermo, cat# 11668030) to determine a positive control. | Gong Lab | |
Nanoparticle | Polymer-RNP nanocapsule | RNP-NC-tri(GalNAc) | The nanocapsule is a thin glutathione (GSH)-cleavable covalently crosslinked polymer coating around a preassembled ribonucleoprotein (RNP) complex between a Cas9 nuclease and a guide RNA. This nanoparticle has a surface modification of hepatocyte-specific targeting ligand triGalNAc to enhance the internalization of NCs by liver cells. | Gong Lab |
Show Experiments (3)
Testing different ratios of Lipofectamine-RNPs after 24 hours for determination of positive control
|
Amphiphilic peptide | S10 | Shuttle peptide used to deliver reagents to airway epithelia | McCray Lab |
Show Experiments (12)
Testing Shuttle Peptides ability to deliver GFP-NLS to airway epithelia.
|
|
Amphiphilic peptide | S10 Scr. | Shuttle peptide used to deliver reagents to airway epithelia | McCray Lab | ||
Amphiphilic peptide | S10-MOD | Shuttle peptide used to deliver reagents to airway epithelia | McCray Lab | ||
Amphiphilic peptide | S10D | Shuttle peptide used to deliver reagents to airway epithelia | McCray Lab | ||
Amphiphilic peptide | S18 | Shuttle peptide | Feldan Therapeutics (synthetic peptide from GL Biochem, 95% purity) | ||
Amphiphilic peptide | S85 | Shuttle peptide | Feldan Therapeutics (synthetic peptide from GL Biochem, 95% purity) | ||
Commercial Reagent | SE Cell Line 4D-Nucleofector™ X Kit S | For efficient transfection of difficult-to-transfect cell lines, e.g. Jurkat or MCF-7, in the 4D-NucleofectorTM X Unit (20 µL format). | Lonza | ||
Virus Like Particle | eVLP | engineered virus like particles | Liu Lab |
Show Experiments (3)
Pcsk9 adenine base editor efficiency in liver and nonliver tissue
|
|
Amphiphilic peptide | endosomolytic peptide | Amphiphilic peptides. Change of conformation upon acidification of the media. Used for their endosomolytic capacities. | Ross Wilson Lab |
Show Experiments (1) |
|
Amphiphilic peptide | endosomolytic peptide and anti-podocyte targeting antibody | Amphiphilic peptides. Change of conformation upon acidification of the media. Used for their endosomolytic capacities. Molecular Targeting Antibody (MTA), anti-podocyte antibody is a protein G purified antibody. Fc binds protein G subunit of the engineered Cas9. | Ross Wilson Lab |
Show Experiments (1) |